Sign up for email alert when new content gets added: Sign up
Kathryn Rees
United Kingdom
Posters & Accepted Abstracts: J Reprod Biol Endocrinol
Fetal Growth Restriction (FGR) is associated with adverse neonatal, post-natal and paediatric outcomes. Early detection via FGR screening allows adequate risk management with emphasis placed on early prenatal care. This review aims to evaluate the usefulness of Abdominal Circumference (AC) in FGR diagnosis and in prediction of associated adverse outcomes. Pubmed, Cochrane and Scopus were systematically searched to find 8 appropriate articles for review. Evidence determined AC to be a useful technique to elucidate fetal growth independently but to be even more accurate in combination with other parameters. This data will inform the practice of obstetricians; selecting those fetuses at risk is necessary for allocation of antenatal testing, appropriate treatment and timely delivery. Limitations of this review included varying population selection, use of retrospective data and the inclusion of both twin and singleton studies. A combined approach of AC and estimated fetal weight (EFW) in FGR diagnosis appears to be the most sensitive and specific criteria. Future research into individualisation of fetal growth study and inclusion of biochemical markers appears promising. References 1. AMartins JG, Biggio JR, Abuhamad A. Society for Maternal-Fetal Medicine consult series #52: diagnosis and management of fetal growth restriction: (replaces Clinical Guideline number 3, April 2012). American Journal Obstetrics and Gynecology. 2020; 223: B2-17. 2. Mifsud W, Sebire NJ. Placental pathology in early-onset and late-onset fetal growth restriction. Fetal Diagnosis. 2014;36:117-128. 3. Lees C, Marlow N, Arabin B, Bilardo CM, Brezinka C, Derks JB, Duvekot J, Frusca T, Diemert A, Ferrazzi E, Ganzevoort W, Hecher K, Martinelli P, Ostermayer E, Papageorghiou AT, Schlembach D, Schneider KT, Thilaganathan B, Todros T, van Wassenaer-Leemhuis A, Valcamonico A, Visser GH, Wolf H. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound in Obstetrics and Gynecology. 2013;42(4):400-8.